Web期刊名称. CURR CANCER DRUG TAR/CURRENT CANCER DRUG TARGETS. ISSN. 1568-0096. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 8.434 (MedSci实 … WebApr 5, 2024 · Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.. The journal …
CURRENT CANCER DRUG TARGETS_影响因子(IF)_中科院分区_SCI …
WebApr 7, 2024 · Drug Design, Development and Therapy will no longer consider meta-analyses for publication. Specific topics covered by the journal include: Drug target … WebSep 15, 2024 · 总体来说,Current Cancer Drug Targets是肿瘤分子药物靶标领域一份相当不错的期刊,影响因子3分+,审稿迅速,认可度高,与肿瘤相关药物靶标在药物化学、药 … philips hue light strip bridge
Nature Cancer
WebCurr Cancer Drug Targets. 2013 Jan;13(1):30-47. Authors ... Other drugs to consider are thalidomide, lenalidomide, antiangiogenic agents, tyrosine kinase inhibitors and heat shock protein 90 inhibitors, which all have both antileukemic and immunomodulatory effects. Relatively few clinical studies are available for patients with this high-risk ... WebCURRENT CANCER DRUG TARGETS. 出版年份:2001 年文章数:29 投稿命中率:43.75%. 出版周期:Monthly 自引率:1.2% 审稿周期:平均2.4月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛. 期刊 ... WebBRAF is a major oncoprotein and oncogenic mutations in BRAF are found in a significant number of cancers, including melanoma, thyroid cancer, colorectal cancer and others. Consequently, BRAF inhibitors have been developed as treatment options for cancers with BRAF mutations which have shown some success in improving patient outcomes in … philips hue lights nz